A complete response letter from the FDA regarding FluMist has elicited a positive reaction at MedImmune Inc., which also reported record revenue as part of its fourth-quarter and year-end earnings. (BioWorld Today)
A complete response letter from the FDA regarding FluMist has elicited a positive reaction at MedImmune Inc., which also reported record revenue as part of its fourth-quarter and year-end earnings. (BioWorld Today)
At first glance, any correlation between biotechnology and auto parts would likely go unnoticed. But such an indirect relationship is integral to GTx Inc., a five-year-old company developing products primarily to treat men's health disorders, in large part with funding from an auto parts scion. (BioWorld Today)
At first glance, any correlation between biotechnology and auto parts would likely go unnoticed. But such an indirect relationship is integral to GTx Inc., a five-year-old company developing products primarily to treat men's health disorders, in large part with funding from an auto parts scion. (BioWorld Today)
Nastech Pharmaceutical Co. Inc. is regaining all rights to a sexual dysfunction product developed for the past year in partnership with Pharmacia Corp., a breakup of sorts brought on by government concerns over a merger between the latter and Pfizer Inc., the maker of Viagra. (BioWorld Today)
